Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Girelli

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Recenti Progressi in Medicina|June 5, 2001
[Genetic risk factors in ischemic cardiopathy]D Girelli, N Martinelli
Recenti Progressi in Medicina|September 1, 1991
[Ion transport in erythrocytes: a universal physiological model. Reflections on the pathogenesis of hypertension]O Olivieri, D Girelli, R Corrocher
Minerva Medica|January 7, 1998
["Hyperferritinemia-cataract syndrome." Description of a new hereditary disease, from anamnesis to molecular diagnosis]D Girelli, P Piccoli, R Corrocher
Haematologica|September 5, 2001
Extensive life-threatening thrombosis in a patient with heparin-induced thrombocytopenia and factor V Leiden mutationF Pizzolo, D Girelli, O Olivieri
Internal Medicine Journal|January 19, 2007
Recurrent needle-tract metastases of hepatocellular carcinoma following fine-needle aspirationC Pavan, A Parisi, D Girelli
Haematologica|September 1, 1990
Red blood cell molecular abnormalities in non haematological diseasesG De Sandre, D Girelli, O Olivieri
Blood|June 1, 1996
Molecular basis for the hereditary hyperferritinemia-cataract syndromeD Girelli, O Olivieri, P Gasparini, et al.
Preventive Medicine|September 1, 1996
Relationships between serum uric acid and lipids in healthy subjectsC Russo, O Olivieri, D Girelli, et al.
The European Journal of Medicine|January 1, 1993
Delayed multiorgan non-neoplastic damage after exposure to radiotherapy in infancyO Olivieri, D Girelli, C Russo, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels?B Lunghi, D Scanavini, D Girelli, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Recenti Progressi in Medicina|June 5, 2001
[Genetic risk factors in ischemic cardiopathy]D Girelli, N Martinelli
Recenti Progressi in Medicina|September 1, 1991
[Ion transport in erythrocytes: a universal physiological model. Reflections on the pathogenesis of hypertension]O Olivieri, D Girelli, R Corrocher
Minerva Medica|January 7, 1998
["Hyperferritinemia-cataract syndrome." Description of a new hereditary disease, from anamnesis to molecular diagnosis]D Girelli, P Piccoli, R Corrocher
Haematologica|September 5, 2001
Extensive life-threatening thrombosis in a patient with heparin-induced thrombocytopenia and factor V Leiden mutationF Pizzolo, D Girelli, O Olivieri
Internal Medicine Journal|January 19, 2007
Recurrent needle-tract metastases of hepatocellular carcinoma following fine-needle aspirationC Pavan, A Parisi, D Girelli
Haematologica|September 1, 1990
Red blood cell molecular abnormalities in non haematological diseasesG De Sandre, D Girelli, O Olivieri
Blood|June 1, 1996
Molecular basis for the hereditary hyperferritinemia-cataract syndromeD Girelli, O Olivieri, P Gasparini, et al.
Preventive Medicine|September 1, 1996
Relationships between serum uric acid and lipids in healthy subjectsC Russo, O Olivieri, D Girelli, et al.
The European Journal of Medicine|January 1, 1993
Delayed multiorgan non-neoplastic damage after exposure to radiotherapy in infancyO Olivieri, D Girelli, C Russo, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels?B Lunghi, D Scanavini, D Girelli, et al.
Pageof 9